Redefining therapeutic landscapes: clinicopathological insights into low and ultra-low HER2 expression in male breast cancer
Male invasive breast cancer is rare, and it is more common in the elderly over 60 years old. The positive rate of ER and PR is high, and the incidence of HER2 low is high. The high HER2 low expression rate of male breast cancer can provide a new anti-HER2 treatment decision.
Authors
- Yueping Liu (ORCID: https://orcid.org/0000-0002-4582-114X)
- Shuyao Niu (ORCID: https://orcid.org/0000-0002-2834-3625)
- Jiuyan Shang
- Xuemei Sun (ORCID: https://orcid.org/0000-0003-3532-7292)
- Jiaxian Miao
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Diagnostic Pathology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1186/s13000-025-01632-3
- Citations
- 4
- Primary Topic
- Male Breast Health Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.51